Welcome to our dedicated page for The Oncology Institute news (Ticker: TOI), a resource for investors and traders seeking the latest updates and insights on The Oncology Institute stock.
The Oncology Institute, Inc. (NASDAQ: TOI) generates a steady flow of news as it pursues its strategy in value-based community oncology care. Founded in 2007, the company describes itself as one of the largest value-based oncology groups in the United States, with over 180 employed and affiliate clinicians and more than 100 clinics and affiliate locations of care across five states. News about TOI often highlights how it combines specialized cancer care with value-based payment models and community-based delivery.
Investors and observers following TOI news can expect updates on financial performance, guidance, and outlook, including revenue mix across patient services, dispensary, and capitation arrangements. The company regularly issues press releases on quarterly results, non-GAAP metrics such as Adjusted EBITDA and Free Cash Flow, and changes to its financial guidance. These items are often accompanied by management commentary on operational trends in areas like pharmacy, dispensary, and delegated contracts.
TOI’s news flow also covers clinical and operational initiatives. Examples include participation in CMS programs such as the Enhancing Oncology Model, where the company has reported Medicare savings and quality scores, as well as the launch of centers of excellence, such as a Lung Cancer Center of Excellence in Florida. Announcements may describe programs like its High Value Cancer Care initiative, 24/7 symptom management support, and efforts to reduce avoidable emergency department visits and admissions.
Another recurring theme in TOI news is technology and leadership. The company has reported partnerships to co-develop AI-enabled administrative automation, and it has announced leadership promotions and board changes that relate to technology strategy, people operations, and financial oversight. For readers tracking TOI, this news page offers a way to follow developments in value-based oncology care, operational efficiency initiatives, and governance updates over time.
The Oncology Institute (TOI) has successfully completed its merger with DFP Healthcare Acquisitions Corp., with the transaction approved on November 12, 2021. This merger establishes TOI as a public company, trading under the new ticker symbols 'TOI' and 'TOIIW' on NASDAQ. The transaction values TOI at $842 million, with a significant cash infusion of approximately $334 million, including $275 million from a private placement. The funds will support expansion initiatives across multiple states, driving TOI's value-based oncology care strategy.